SCHEMBL6169048

SCHEMBL6169048

CCOC(=O)c1ccc([N+](=O)[O-])c(NC(=O)Cc2ccccc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
KMT2A Q03164 2/20 0.57
MAPK8 P45983 1/20 0.56
MAPK9 P45984 1/20 0.56
MAPK10 P53779 1/20 0.56
MAPT P10636 8/20 0.53
ALDH1A1 P00352 6/20 0.53
RAB9A P51151 2/20 0.53
NPC1 O15118 1/20 0.53
CRHBP P24387 1/20 0.53
CRHR2 Q13324 1/20 0.53
LMNA P02545 3/20 0.52
POLB P06746 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 1/20 0.52
GAA P10253 1/20 0.52
HTT P42858 2/20 0.52
PTGER4 P35408 1/20 0.50
MAPK1 P28482 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169345 0.91 KMT2A (0.69) PKML3MBTL1KMT2AMAPK8MAPK9
SCHEMBL6169173 0.89 MAPT (0.65) PKMKMT2AMAPTALDH1A1RAB9A
SCHEMBL8057592 0.87 HTT (0.58) PKMKMT2AMAPTALDH1A1RAB9A
SCHEMBL6169035 0.86 RAB9A (0.59) PKML3MBTL1KMT2AMAPTALDH1A1
SCHEMBL6170373 0.86 KMT2A (0.64) PKML3MBTL1KMT2AMAPTALDH1A1
SCHEMBL6170252 0.85 KMT2A (0.60) PKMKMT2AMAPTALDH1A1RAB9A
SCHEMBL1608610 0.84 ALOX15 (0.58) PKMKMT2AMAPTALDH1A1RAB9A
SCHEMBL6171410 0.84 ALDH1A1 (0.63) PKML3MBTL1KMT2AMAPTALDH1A1
SCHEMBL8129523 0.83 ALDH1A1 (0.58) PKMKMT2AMAPTALDH1A1RAB9A
SCHEMBL6169157 0.83 KMT2A (0.60) PKML3MBTL1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed